Drug News

Medindia's Press Release’ section provides the latest press release on Drug from across the world for the global audience. This page links to 12872 Drug press releases.

Positive Response from European Regulatory Procedure Supports Approval of Elvanse® (lisdexamfetamine dimesylate) for ADHD

new psychotic symptoms such as: hearing voices believing things that are not true being suspicious new manic symptoms? This is not a complete summary of safety information. For additional safety ...


FDA Approves GlaxoSmithKline's four-strain seasonal influenza vaccine for use in the U.S.

LONDON , Dec. 17, 2012 /PRNewswire/ -- GlaxoSmithKline plc [LSE/NYSE: GSK] announced today that the U.S. Food and Drug Administration (FDA) has approved FLUARIX® QUADRIVALENT (Influenza Virus Vaccine) for the immunisation of children (three ...

ConvaTec Announces New Use of AQUACEL® Foam Dressing to Protect Against Skin Breakdown Caused by Friction and Moisture

Study finds 75% reduction in skin-damaging friction compared to Mepilex® Border dressing[1] SKILLMAN, N.J. , Dec. 17, 2012 /PRNewswire/ -- ConvaTec, a world-leading developer and marketer of innovative medical technologies, today ...

Andrew Technologies Receives FDA 510 (k) Clearance for Commercial Version of HydraSolve™ Lipoplasty System

IRVINE, Calif. , Dec. 17, 2012 /PRNewswire/ -- Andrew Technologies, LLC received FDA 510 (k) clearance for the commercially manufactured version of the HydraSolve™ Lipoplasty System, having successfully completed design ...

Lexicon's Drug Candidate For Irritable Bowel Syndrome Receives Fast Track Status From The FDA

THE WOODLANDS, Texas , Dec. 17, 2012 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc . (Nasdaq: LXRX), a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, announced today that it has ...

Patented Multipurpose Topical Pain Reliever Formula for Sale by ICAP Patent Brokerage

CHICAGO , Dec. 17, 2012 /PRNewswire/ --  ICAP Patent Brokerage announces for sale a patented method for creating an improved topical analgesic cream from MyoRX Corp., which can be used to treat arthritis and other chronic pain syndromes as ...

Medical Marijuana Dispensary Blazes the Trail for Community Service

Zen Healing of West Hollywood is there for the Veteran Patient Community WEST HOLLYWOOD, Calif. , Dec. 17, 2012 /PRNewswire-iReach/ -- Over the past 9 years, humanitarian Andrew Kramer , owner of  Zen Healing of West Hollywood , ...

GSK receives FDA approval for raxibacumab anti-toxin for the treatment of inhalational anthrax

LONDON , Dec. 14, 2012 /PRNewswire/ -- GlaxoSmithKline plc [LSE/NYSE: GSK] announced today that the U.S. Food and Drug Administration (FDA) has approved raxibacumab for the treatment of adult and pediatric patients with inhalational anthrax ...

LegitScript Shuts Down Rogue Internet Pharmacy "Mothership"

MyRxCash.com tied to unapproved online drug sales by drug safety regulators PORTLAND, Ore. , Dec. 13, 2012 /PRNewswire/ -- Internet pharmacy monitoring and compliance firm LegitScript announced that it shut down myrxcash.com , an Internet ...

MAQUET Cardiovascular Announces U.S. Food and Drug Administration Panel Votes To Reclassify Intra-Aortic Balloon Pumps To A Class II Designation In Certain Indications

--Reclassification Allows MAQUET to Rapidly Bring New Product Offerings to Market to Continually Meet Clinician and Patient Needs-- WAYNE, N.J. , Dec. 13, 2012 /PRNewswire/ -- MAQUET Cardiovascular, the leader in ...

Drug News »

Alectinib: Adjuvant Treatment for Lung Cancer Approved by US FDA

Alectinib: Adjuvant Treatment for Lung Cancer Approved by US FDA

Alectinib, a molecule developed by Genentech, Inc has been granted approval by the Food and Drug Administration on April 18, 2024, for the adjuvant treatment of patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer ...

US FDA Approval of N-803: Ray of Hope For Bladder Cancer Patients

US FDA Approval of N-803: Ray of Hope For Bladder Cancer Patients

The immunotherapy-boosting drug N-803, with the brand name Anktiva, was granted approval by the U.S. Food and Drug Administration (FDA) on April 22, 2024, based on the positive outcome of a clinical trial ...

Resmetirom For MASH: Approved by US FDA, Increase in Partnerships

Resmetirom For MASH: Approved by US FDA, Increase in Partnerships

Biopharmaceutical companies are once again competing in the development of innovative drugs for metabolic dysfunction-associated steatohepatitis (MASH), after a series of failures faced by drug manufacturers. The US FDA approval of ...

Semaglutide: A Dominant Player for Patients With Heart Failure

Semaglutide: A Dominant Player for Patients With Heart Failure

A study was presented by the Gardy Health system in Atlanta, Georgia, US, at the 73rd Annual Scientific Session of the American College of Cardiology. The study was conducted to evaluate the frequency of heart failure hospitalizations (HFH) in ...

Physician's Lack Agreement – Patients Prefer Branded or Generic Drugs?

Physician's Lack Agreement – Patients Prefer Branded or Generic Drugs?

Generic drugs and Branded drugs are essentially the same, as they both have the same active ingredient. Generic drugs can provide the same therapeutic advantages as branded drugs at a reduced cost, as they do not have to undergo extensive ...

More Drug News

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.